兽用支架市场机会、成长要素、产业趋势分析及2026-2035年预测

预计到 2025 年，全球兽用支架市场价值将达到 4,750 万美元，并预计以 7% 的复合年增长率成长，到 2035 年达到 9,200 万美元。

兽用支架市场的成长主要得益于人们对改善动物健康和提高兽医治疗标准的日益关注。随着全球宠物数量的持续增长，兽医和宠物饲主越来越重视能够改善伴侣动物生活品质的有效医疗干预措施。兽用支架正日益被认可为治疗动物重要内道结构性狭窄或阻塞的重要选择。同时，技术的快速发展显着提高了这些器械的性能和可靠性。除了微创兽医手术的发展外，支架设计的改进和先进生物材料的引入也提高了植入手术的成功率。此外，影像和留置技术的进步使兽医能够提供更精准、更有效率的治疗。这些进步有助于改善临床疗效，加速动物康復，并降低併发症率。因此，兽用支架正逐渐被兽医专业人士广泛接受，并赢得了寻求先进治疗方法的宠物饲主的信任。

兽用支架是一种专门设计的植入，用于治疗因疾病、创伤或发育异常而导致特定内道阻塞或狭窄的动物。这些圆柱形装置通常由耐用的金属合金或聚合物材料製成，并植入管状解剖结构中，以维持正常的通道通畅并恢復正常的生理功能。兽用支架透过为受影响区域提供结构支撑，根据其植入位置的不同，有助于改善气流、血液循环或体液流动。

预计到2025年，气道支架市场规模将达到1,870万美元。该市场的成长主要与伴侣动物气道相关疾病发生率的上升有关，这些疾病需要长期在呼吸系统内提供结构支撑。此类疾病会导致严重的呼吸窘迫，需要即时进行医疗干预以恢復足够的通气量。兽医和宠物饲主对微创治疗方法的日益青睐也促进了气道支架使用的增加。此外，支架材料工程的进步，包括自膨胀金属合金和先进的生物可降解材料，正在提高器械性能并拓展其在兽医临床中的应用。

预计到2025年，犬类市场将占据60.6%的市场。这一市场扩张归因于犬类疾病盛行率的上升，而这些疾病需要支架辅助治疗。影响呼吸系统、泌尿器官系统和血管系统的各种结构性併发症可能需要植入支架以恢復正常的生理功能。全球宠物犬数量的庞大以及兽医支出的不断增长进一步推动了该领域的成长。兽医越来越多地将支架手术作为治疗方法犬类重要内部通道结构性狭窄或阻塞的有效方法。

预计到2025年，北美兽用支架市占率将达到41.5%。该地区的主导地位主要归功于其高度发展的兽医基础设施以及宠物先进治疗方案的广泛普及。在北美，众多专科动物医院、转诊中心和先进的临床设施均配备了进行包括支架植入在内的复杂微创手术的设备。此外，消费者在宠物医疗保健方面的强劲支出以及宠物保险计划的普及，也有助于降低先进兽医手术的费用负担。这些因素共同推动了创新兽医解决方案的普及，并支撑着全部区域兽用支架市场的持续成长。

目录

第一章：调查方法和范围

第二章执行摘要

第三章业界考察

• 生态系分析
• 影响产业的因素
  • 促进因素
    • 宠物数量增加
    • 呼吸道和泌尿器官系统疾病的盛行率
    • 人们越来越关注宠物健康，但医疗成本也不断上涨。
  • 产业潜在风险与挑战
    • 兽医支架和手术高成本
    • 支架相关併发症的风险
  • 市场机会
    • 扩大专业动物医院及转诊中心
    • 兽医介入设备的技术进步
• 成长潜力分析
• 监理情势（基于初步调查）
  • 北美洲
  • 欧洲
  • 亚太地区
• 技术与创新趋势（基于初步调查）
  • 目前技术
  • 新兴技术
• 价格分析（基于初步调查）
• 人工智慧对市场的影响
• 波特五力分析
• PESTEL 分析

第四章 竞争情势

• 介绍
• 企业市占率分析
• 企业矩阵分析
• 主要市场公司的竞争分析
• 竞争定位矩阵
• 主要进展
  • 併购
  • 伙伴关係与合作
  • 新产品发布
  • 业务拓展计划

第五章 市场估价与预测：依产品划分，2022-2035年

• 气道支架
• 血管支架
• 尿道支架
• 其他支架

第六章 市场估计与预测：依动物种类划分，2022-2035年

• 狗
• 猫
• 其他动物

第七章 市场估计与预测：依应用领域划分，2022-2035年

• 气道阻塞
• 血管阻塞
• 泌尿道阻塞
• 其他用途

第八章 市场估算与预测：依材料划分，2022-2035年

• 镍钛诺
• 可生物降解聚合物

第九章 市场估计与预测：依最终用途划分，2022-2035年

• 兽医医院和诊所
• 其他最终用户

第十章 市场估价与预测：依地区划分，2022-2035年

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国

第十一章：公司简介

• AbtVet（Stening group）
• Create Medic
• Dextronix
• EpiicVet
• Infiniti Medical
• MI Tech
• TaeWoong Medical
• UltraVet Medical Devices

The Global Veterinary Stents Market was valued at USD 47.5 million in 2025 and is estimated to grow at a CAGR of 7% to reach USD 92 million by 2035.

Growth in the veterinary stents market is strongly influenced by the increasing focus on improving animal health and advancing treatment standards within veterinary medicine. As pet ownership continues to rise globally, veterinarians and pet owners are placing greater emphasis on effective medical interventions that enhance the quality of life for companion animals. Veterinary stents are increasingly recognized as an important treatment option for animals experiencing structural narrowing or blockages in vital body passages. At the same time, rapid technological advancements have significantly improved the performance and reliability of these devices. The development of minimally invasive veterinary procedures, along with improved stent designs and advanced biomaterials, has enhanced the success rate of implantation procedures. In addition, improvements in imaging and placement technologies are enabling veterinarians to deliver more precise and efficient treatments. These advancements are contributing to better clinical outcomes, faster recovery for animals, and reduced complication rates. As a result, veterinary stents are gaining wider acceptance among veterinary professionals while also receiving greater trust from pet owners seeking advanced treatment options.

Veterinary stents function as specialized implants designed to treat animals experiencing blockages or narrowing within certain internal pathways caused by disease, injury, or developmental abnormalities. These cylindrical devices are typically manufactured using durable metal alloys or polymer-based materials and are inserted into tubular anatomical structures to maintain proper passage and restore normal physiological function. By providing structural support within affected areas, veterinary stents help improve airflow, circulation, or fluid movement, depending on the location of placement.

The airway stents segment generated USD 18.7 million in 2025. Segment growth is primarily associated with the rising incidence of airway-related disorders among companion animals that require long-term structural support within the respiratory tract. Such conditions can lead to severe breathing complications and require immediate medical intervention to restore proper airflow. The growing preference among veterinarians and pet owners for minimally invasive treatment approaches has contributed to the increased use of airway stents. Additionally, advancements in stent material engineering, including self-expanding metal alloys and modern biodegradable materials, have improved device performance and expanded their clinical use within veterinary practices.

The dogs segment held 60.6% share in 2025. Market expansion within this segment is driven by the rising occurrence of medical conditions in canine populations that require stent-based treatment. Various structural complications affecting the respiratory, urinary, and vascular systems can require intervention through stent placement to restore normal physiological function. The high global population of companion dogs and increasing spending on veterinary healthcare further support the growth of this segment. Veterinarians are increasingly utilizing stent procedures as an effective treatment solution for dogs experiencing structural narrowing or obstructions within critical internal pathways.

North America Veterinary Stents Market accounted for 41.5% share in 2025. The region's leadership position is largely supported by its highly developed veterinary healthcare infrastructure and widespread availability of advanced treatment options for companion animals. Numerous specialized veterinary hospitals, referral centers, and advanced clinical facilities across North America are equipped to perform complex minimally invasive procedures, including stent implantation. In addition, strong consumer spending on pet healthcare and the availability of pet insurance programs contribute to greater affordability for advanced veterinary procedures. These factors collectively encourage the adoption of innovative veterinary treatment solutions and support the continued growth of the veterinary stents market across the region.

Key companies operating in the Global Veterinary Stents Market include Infiniti Medical, Dextronix, TaeWoong Medical, UltraVet Medical Devices, Create Medic, M.I. Tech, AbtVet (Stening Group), and EpiicVet. Companies competing in the Veterinary Stents Market are implementing several strategic initiatives to strengthen their market presence and expand global reach. Leading manufacturers are focusing heavily on research and development to introduce advanced stent designs with improved durability, flexibility, and biocompatibility. Many companies are also investing in the development of innovative materials and minimally invasive delivery systems to enhance treatment effectiveness and simplify clinical procedures for veterinarians. Strategic collaborations with veterinary hospitals, specialty clinics, and research institutions are helping companies improve product adoption and clinical validation. Additionally, market participants are expanding their distribution networks and strengthening regional partnerships to increase accessibility to veterinary stent technologies across emerging markets while maintaining strong competitiveness in established veterinary healthcare sectors.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research approach
• 1.3 Quality commitments
  • 1.3.1 GMI AI policy and data integrity commitment
    • 1.3.1.1 Source consistency protocol
• 1.4 Research trail and confidence scoring
  • 1.4.1 Research trail components
  • 1.4.2 Scoring components
• 1.5 Data collection
  • 1.5.1 Partial list of primary sources
• 1.6 Data mining sources
  • 1.6.1 Paid sources
    • 1.6.1.1 Sources, by region
• 1.7 Base estimates and calculations
  • 1.7.1 Revenue share analysis
  • 1.7.2 Base year calculation
• 1.8 Forecast model
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Animal trends
  • 2.2.4 Application trends
  • 2.2.5 Material trends
  • 2.2.6 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet ownership
    • 3.2.1.2 Prevalence of respiratory and urological disorders
    • 3.2.1.3 Growing awareness of pet health and healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of veterinary stents and procedures
    • 3.2.2.2 Risk of stent-related complications
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of veterinary specialty hospitals and referral centers
    • 3.2.3.2 Technological advancements in veterinary interventional devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape (Driven by Primary Research)
  • 3.5.1 Current technologies
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis (Driven by Primary Research)
• 3.7 Impact of AI on the market
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Airway stents
• 5.3 Vascular stents
• 5.4 Urethral stents
• 5.5 Other stents

Chapter 6 Market Estimates and Forecast, By Animal, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Dogs
• 6.3 Cats
• 6.4 Other animals

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Airway collapse
• 7.3 Vascular obstructions
• 7.4 Urinary tract obstructions
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Nitinol
• 8.3 Biodegradable polymer

Chapter 9 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary hospitals and clinics
• 9.3 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 AbtVet (Stening group)
• 11.2 Create Medic
• 11.3 Dextronix
• 11.4 EpiicVet
• 11.5 Infiniti Medical
• 11.6 M.I. Tech
• 11.7 TaeWoong Medical
• 11.8 UltraVet Medical Devices